Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
648 | 11882 | 38.4 | 79% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
648 | 3 | ADVANCED GLYCATION END PRODUCTS//HMGB1//METHYLGLYOXAL | 11882 |
1179 | 2 | ADVANCED GLYCATION END PRODUCTS//METHYLGLYOXAL//GLYCATION | 9308 |
2989 | 2 | HMGB1//HIGH MOBILITY GROUP BOX 1//HIGH MOBILITY GROUP BOX 1 PROTEIN | 2574 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ADVANCED GLYCATION END PRODUCTS | authKW | 1227598 | 8% | 54% | 893 |
2 | HMGB1 | authKW | 972749 | 5% | 63% | 606 |
3 | METHYLGLYOXAL | authKW | 908412 | 5% | 62% | 570 |
4 | GLYCATION | authKW | 895926 | 6% | 49% | 714 |
5 | RAGE | authKW | 765132 | 4% | 61% | 492 |
6 | RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS | authKW | 389479 | 2% | 69% | 220 |
7 | HIGH MOBILITY GROUP BOX 1 | authKW | 384077 | 2% | 60% | 251 |
8 | AGES | authKW | 287443 | 2% | 51% | 221 |
9 | GLYCATED ALBUMIN | authKW | 261256 | 1% | 67% | 153 |
10 | ADVANCED GLYCATION END PRODUCTS AGES | authKW | 240669 | 1% | 59% | 160 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Medical Laboratory Technology | 19594 | 7% | 1% | 825 |
2 | Endocrinology & Metabolism | 15823 | 15% | 0% | 1781 |
3 | Biochemistry & Molecular Biology | 6364 | 23% | 0% | 2697 |
4 | Medicine, Research & Experimental | 2871 | 7% | 0% | 822 |
5 | Cell Biology | 1469 | 8% | 0% | 919 |
6 | Urology & Nephrology | 1300 | 4% | 0% | 452 |
7 | Biophysics | 1284 | 5% | 0% | 579 |
8 | Food Science & Technology | 677 | 4% | 0% | 465 |
9 | Geriatrics & Gerontology | 640 | 2% | 0% | 181 |
10 | Chemistry, Medicinal | 640 | 3% | 0% | 352 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CMRI | 90485 | 1% | 49% | 72 |
2 | PATHOPHYSIOL THER EUT DIABET VASC COMPLIC | 83815 | 1% | 41% | 79 |
3 | BIOCHEM MOL VASC BIOL | 81927 | 0% | 60% | 53 |
4 | EXPT DIABET AGING | 67489 | 0% | 56% | 47 |
5 | CHROMATIN DYNAM UNIT | 40434 | 0% | 75% | 21 |
6 | MED CLIN CHEM 1 | 31795 | 0% | 31% | 40 |
7 | NEUROIMMUNOL CELL BIOL UNIT | 28882 | 0% | 75% | 15 |
8 | PATHOPHYSIOL SCI | 27181 | 0% | 21% | 51 |
9 | METAB VASC MED | 17311 | 0% | 38% | 18 |
10 | FOOD REGULAT BIOL | 17113 | 0% | 67% | 10 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DIABETES CARE | 11657 | 2% | 2% | 231 |
2 | CLINICAL CHEMISTRY | 8567 | 2% | 2% | 202 |
3 | ANNALS OF CLINICAL BIOCHEMISTRY | 8529 | 1% | 3% | 107 |
4 | DIABETES | 7096 | 2% | 2% | 186 |
5 | DIABETOLOGIA | 7084 | 1% | 2% | 154 |
6 | CLINICA CHIMICA ACTA | 6609 | 1% | 2% | 172 |
7 | DIABETES RESEARCH AND CLINICAL PRACTICE | 6218 | 1% | 2% | 115 |
8 | MOLECULAR MEDICINE | 5477 | 0% | 4% | 58 |
9 | DIABETIC MEDICINE | 4339 | 1% | 2% | 100 |
10 | DIABETES & METABOLISM | 4301 | 1% | 2% | 70 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ADVANCED GLYCATION END PRODUCTS | 1227598 | 8% | 54% | 893 | Search ADVANCED+GLYCATION+END+PRODUCTS | Search ADVANCED+GLYCATION+END+PRODUCTS |
2 | HMGB1 | 972749 | 5% | 63% | 606 | Search HMGB1 | Search HMGB1 |
3 | METHYLGLYOXAL | 908412 | 5% | 62% | 570 | Search METHYLGLYOXAL | Search METHYLGLYOXAL |
4 | GLYCATION | 895926 | 6% | 49% | 714 | Search GLYCATION | Search GLYCATION |
5 | RAGE | 765132 | 4% | 61% | 492 | Search RAGE | Search RAGE |
6 | RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS | 389479 | 2% | 69% | 220 | Search RECEPTOR+FOR+ADVANCED+GLYCATION+END+PRODUCTS | Search RECEPTOR+FOR+ADVANCED+GLYCATION+END+PRODUCTS |
7 | HIGH MOBILITY GROUP BOX 1 | 384077 | 2% | 60% | 251 | Search HIGH+MOBILITY+GROUP+BOX+1 | Search HIGH+MOBILITY+GROUP+BOX+1 |
8 | AGES | 287443 | 2% | 51% | 221 | Search AGES | Search AGES |
9 | GLYCATED ALBUMIN | 261256 | 1% | 67% | 153 | Search GLYCATED+ALBUMIN | Search GLYCATED+ALBUMIN |
10 | ADVANCED GLYCATION END PRODUCTS AGES | 240669 | 1% | 59% | 160 | Search ADVANCED+GLYCATION+END+PRODUCTS+AGES | Search ADVANCED+GLYCATION+END+PRODUCTS+AGES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KANG, R , CHEN, RC , ZHANG, QH , HOU, W , WU, S , CAO, LZ , HUANG, J , YU, Y , FAN, XG , YAN, ZW , ET AL (2014) HMGB1 IN HEALTH AND DISEASE.MOLECULAR ASPECTS OF MEDICINE. VOL. 40. ISSUE . P. 1 -116 | 762 | 45% | 76 |
2 | POULSEN, MW , HEDEGAARD, RV , ANDERSEN, JM , DE COURTEN, B , BUGEL, S , NIELSEN, J , SKIBSTED, LH , DRAGSTED, LO , (2013) ADVANCED GLYCATION ENDPRODUCTS IN FOOD AND THEIR EFFECTS ON HEALTH.FOOD AND CHEMICAL TOXICOLOGY. VOL. 60. ISSUE . P. 10 -37 | 218 | 74% | 84 |
3 | VETTER, SW , (2015) GLYCATED SERUM ALBUMIN AND AGE RECEPTORS.ADVANCES IN CLINICAL CHEMISTRY, VOL 72. VOL. 72. ISSUE . P. 205 -275 | 244 | 78% | 2 |
4 | ANDERSSON, U , TRACEY, KJ , (2011) HMGB1 IS A THERAPEUTIC TARGET FOR STERILE INFLAMMATION AND INFECTION.ANNUAL REVIEW OF IMMUNOLOGY, VOL 29. VOL. 29. ISSUE . P. 139 -162 | 109 | 81% | 417 |
5 | MAESSEN, DEM , STEHOUWER, CDA , SCHALKWIJK, CG , (2015) THE ROLE OF METHYLGLYOXAL AND THE GLYOXALASE SYSTEM IN DIABETES AND OTHER AGE-RELATED DISEASES.CLINICAL SCIENCE. VOL. 128. ISSUE 12. P. 839 -861 | 162 | 76% | 20 |
6 | STINGHEN, AEM , MASSY, ZA , VLASSARA, H , STRIKER, GE , BOULLIER, A , (2016) UREMIC TOXICITY OF ADVANCED GLYCATION END PRODUCTS IN CKD.JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. VOL. 27. ISSUE 2. P. 354 -370 | 139 | 60% | 13 |
7 | XIE, JL , MENDEZ, JD , MENDEZ-VALENZUELA, V , AGUILAR-HERNANDEZ, MM , (2013) CELLULAR SIGNALLING OF THE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE).CELLULAR SIGNALLING. VOL. 25. ISSUE 11. P. 2185-2197 | 134 | 74% | 95 |
8 | OTT, C , JACOBS, K , HAUCKE, E , SANTOS, AN , GRUNE, T , SIMM, A , (2014) ROLE OF ADVANCED GLYCATION END PRODUCTS IN CELLULAR SIGNALING.REDOX BIOLOGY. VOL. 2. ISSUE . P. 411 -429 | 132 | 62% | 107 |
9 | GOLDIN, A , BECKMAN, JA , SCHMIDT, AM , CREAGER, MA , (2006) ADVANCED GLYCATION END PRODUCTS - SPARKING THE DEVELOPMENT OF DIABETIC VASCULAR INJURY.CIRCULATION. VOL. 114. ISSUE 6. P. 597-605 | 104 | 83% | 713 |
10 | REYNAERT, NL , GOPAL, P , RUTTEN, EPA , WOUTERS, EFM , SCHALKWIJK, CG , (2016) ADVANCED GLYCATION END PRODUCTS AND THEIR RECEPTOR IN AGE-RELATED, NON-COMMUNICABLE CHRONIC INFLAMMATORY DISEASES; OVERVIEW OF CLINICAL EVIDENCE AND POTENTIAL CONTRIBUTIONS TO DISEASE.INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. VOL. 81. ISSUE . P. 403 -418 | 174 | 75% | 0 |
Classes with closest relation at Level 3 |